Eli Lilly plans four new U.S. manufacturing sites, expanding domestic production and reshoring pharmaceutical ingredient manufacturing. $50B expansion since 2020 includes four sites, creating over ...

Eli Lilly together with Sanofi and Novo Nordisk make up 90% of the US market for insulin. Following the announcement, Lilly’s shares were up 1.3% at $315.30 and, on Tuesday, President Biden ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Insulin is a hormone that allows glucose in the blood to enter cells, providing them with the energy to function. A lack of adequate insulin plays a key role in the development of diabetes ...

Just days after Eli Lilly announced plans to cut the price of its insulin products in the US, Novo Nordisk has followed suit with reductions of up to 75% from the start of next year. The discount ...

Compounding pharmacies that have been selling hundreds of thousands of doses of copies of Lilly's Zepbound and Novo's Wegovy while the medicines were in shortage are running out of time to produce ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

At the same time, Novo Nordisk has expressed plans to launch the drug in India, although the Danish company has not clarified a timeline. Innovator Eli Lilly, whose weight loss drug Tirzepatide is ...

Eli Lilly is growing faster with Zepbound and Mounjaro, as the active ingredient tirzepitide offers a more effective result. Novo Nordisk also cut profits in the second quarter due to weaker ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other oversold pharma stocks to buy according to analysts. On February 20, Emily Field ...

The Unrivaled 3v3 league continues with a matchup between Laces BC and Mist BC. The Laces, currently second in the standings with a 5-4 record, will face off against the sixth-place Mist, who ...